Search research articles
Contact Us
Filters
Showing results (101-110 of 115) with videos related to
Page
of 12
Sort By:
British Journal of Cancer
|
July 9, 2004
A phase II feasibility study of carboplatin followed by sequential weekly paclitaxel and gemcitabine as first-line treatment for ovarian cancer
M Harries, C Moss, T Perren, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Economic Burden of Melanoma in Three European Countries: A Retrospective Observational Study
I Kontoudis, M Harries, P Mohr, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 29, 2014
Age at diagnosis and distant metastasis in breast cancer--a surprising inverse relationship
A Purushotham, E Shamil, M Cariati, et al.
The British Journal of Dermatology
|
January 24, 2017
Frontal fibrosing alopecia in men: an association with facial moisturizers and sunscreens
A Debroy Kidambi, K Dobson, S Holmes, et al.
The British Journal of Dermatology
|
July 17, 2013
Treatment patterns, outcomes, and resource utilization of patients with metastatic melanoma in the U.K.: the MELODY study
P Lorigan, M Marples, M Harries, et al.
The British Journal of Dermatology
|
July 18, 2017
Establishing and prioritizing research questions for the prevention, diagnosis and treatment of hair loss (excluding alopecia areata): the Hair Loss Priority Setting Partnership
A Macbeth, J Tomlinson, A Messenger, et al.
Environmental Health Perspectives
|
March 23, 2004
Clofibrate-induced gene expression changes in rat liver: a cross-laboratory analysis using membrane cDNA arrays
Valerie A Baker, Helen M Harries, Jeff F Waring, et al.
Human Gene Therapy
|
June 12, 1999
Gene therapy with autologous, interleukin 2-secreting tumor cells in patients with malignant melanoma
K Palmer, J Moore, M Everard, et al.
British Journal of Cancer
|
July 14, 2011
Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies
T Eisen, R Marais, A Affolter, et al.
Clinical and Experimental Dermatology
|
November 26, 2021
Frontal fibrosing alopecia: survey of severity assessment methods in routine clinical practice and validation of the International Frontal Fibrosing Alopecia Cooperative Group measurement guidance
D M Cummins, C Marshall, L Asfour, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 115) with videos related to
Sort By:
Page
of 12
British Journal of Cancer
|
July 9, 2004
A phase II feasibility study of carboplatin followed by sequential weekly paclitaxel and gemcitabine as first-line treatment for ovarian cancer
M Harries, C Moss, T Perren, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Economic Burden of Melanoma in Three European Countries: A Retrospective Observational Study
I Kontoudis, M Harries, P Mohr, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 29, 2014
Age at diagnosis and distant metastasis in breast cancer--a surprising inverse relationship
A Purushotham, E Shamil, M Cariati, et al.
The British Journal of Dermatology
|
January 24, 2017
Frontal fibrosing alopecia in men: an association with facial moisturizers and sunscreens
A Debroy Kidambi, K Dobson, S Holmes, et al.
The British Journal of Dermatology
|
July 17, 2013
Treatment patterns, outcomes, and resource utilization of patients with metastatic melanoma in the U.K.: the MELODY study
P Lorigan, M Marples, M Harries, et al.
The British Journal of Dermatology
|
July 18, 2017
Establishing and prioritizing research questions for the prevention, diagnosis and treatment of hair loss (excluding alopecia areata): the Hair Loss Priority Setting Partnership
A Macbeth, J Tomlinson, A Messenger, et al.
Environmental Health Perspectives
|
March 23, 2004
Clofibrate-induced gene expression changes in rat liver: a cross-laboratory analysis using membrane cDNA arrays
Valerie A Baker, Helen M Harries, Jeff F Waring, et al.
Human Gene Therapy
|
June 12, 1999
Gene therapy with autologous, interleukin 2-secreting tumor cells in patients with malignant melanoma
K Palmer, J Moore, M Everard, et al.
British Journal of Cancer
|
July 14, 2011
Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies
T Eisen, R Marais, A Affolter, et al.
Clinical and Experimental Dermatology
|
November 26, 2021
Frontal fibrosing alopecia: survey of severity assessment methods in routine clinical practice and validation of the International Frontal Fibrosing Alopecia Cooperative Group measurement guidance
D M Cummins, C Marshall, L Asfour, et al.
Page
of 12